JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B5246 740 Y-P
5 Citation

Target: PI3K

Summary: PI 3-kinase activator,cell permeable

≥163.54 mg/mL
B4660 PI-3065

Target: PI3K

Summary: P110δkinase inhibitor

≥22.7 mg/mL
A3005 CAL-101 (Idelalisib, GS-1101)
2 Citation

Target: PI3K

Summary: PI3K inhibitor
A3010 MK-2206 dihydrochloride
21 Citation

Target: Akt

Summary: Akt1/2/3 inhibitor

insoluble in EtOH; ≥12.01 mg/mL
A3011 CHIR-99021 (CT99021)
2 Citation

Target: GSK-3

Summary: GSK-3 inhibitor, Cell-permeable, ATP-competitive

≥23.27 mg/mL
A3015 BKM120
1 Citation

Target: PI3K

Summary: Inhibitor of pan-Class I PI3K

≥20.52 mg/mL
A3368 DMAT
2 Citation

Target: Pim|CK2|HIPK2|HIPK3

Summary: CK2 inhibitor,potent and selective

≥23.85 mg/mL
A3570 LY2090314

Target: GSK-3

Summary: Potent GSK-3 inhibitor

insoluble in H2O; ≥91 mg/mL
A3861 TBB
1 Citation

Target: CK2

Summary: Casein kinase-2 (CK2) inhibitor

insoluble in H2O; ≥159.2 mg/mL
A3894 TTP 22
1 Citation

Target: CK2

Summary: CK2 inhibitor

insoluble in H2O; ≥16.5 mg/mL